🇨🇦 PF-07104091 monotherapy dose expansion (ovarian) in Canada

PF-07104091 monotherapy dose expansion (ovarian) (pf-07104091-monotherapy-dose-expansion-ovarian) regulatory status in Canada.

Marketing authorisation

PF-07104091 monotherapy dose expansion (ovarian) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Canada

Frequently asked questions

Is PF-07104091 monotherapy dose expansion (ovarian) approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for PF-07104091 monotherapy dose expansion (ovarian) in Canada?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.